Brief: Neovacs raises EUR 6.0 million in private placement with U.S. biotechnology institutional investors

Neovacs SA

31/07/2017 06:30

July 31 (Reuters) - NEOVACS SA  ALNEV.PA : 
    * REG-NEOVACS: SUCCESSFULLY RAISES 6.0 MILLION IN PRIVATE 
PLACEMENT WITH U.S. BIOTECHNOLOGY INSTITUTIONAL INVESTORS 
    * WILL ISSUE A TOTAL OF 9,230,769 ORDINARY SHARES WITH 
ATTACHED EQUITY WARRANTS AT A PRICE OF EUR 0.65 PER SHARE 
    * WARRANTS TO ENTITLE THEIR HOLDERS TO PURCHASE UP TO 
7,846,154 ADDITIONAL ORDINARY SHARES AT EXERCISE PRICE OF EUR 
1.00 PER SHARE 
    * SETTLEMENT OF NEW SHARES SHOULD TAKE PLACE NO LATER THAN 
AUGUST 3, 2017 
    * HAS COMMITTED TO REQUEST LISTING OF WARRANTS ON EURONEXT 
GROWTH PARIS BY SEPTEMBER 30, 2017 
 
Source text for Eikon:  ID:nGNE592lSJ  
Further company coverage:  ALNEV.PA  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))